HOME >> BIOLOGY >> NEWS
Injection drug use the most important risk factor for HIV and HCV infections among Quebec prisoners

In this issue of CMAJ, 2 research groups report on the prevalence of HIV and hepatitis C virus (HCV) infections in different inmate populations: people in provincial prisons in Quebec, and adult and young offenders admitted to remand facilities (jails, detention centres and youth centres) in Ontario. The Quebec study is highlighted below; the Ontario study appears in a separate release posted at EurekAlert today. In both the studies, injection drug use was the most important risk factor, and the prevalence of hepatitis C virus (HCV) infection was much higher than that of HIV infection. Given the high rates of recidivism and the short stays in remand facilities and provincial prisons, the results of these studies have important public health implications and point to the need for preventive measures.

In the Quebec study, Dr. Cline Poulin and colleagues gathered data from 1607 inmates (1357 men and 250 women) at 7 provincial prisons, where sentences of less than 2 years are served. The overall prevalence of HIV infection was 3.4% (8.8% among the women, and 2.4% among the men). In addition, 18.5% of the study subjects (29.2% of the women and 16.6% of the men) tested positive for HCV antibodies. Most of the HIV-positive men (68.8%) and women (59.1%) also had HCV infection. Interestingly, 20% of the HIV-positive inmates and 40% of the HCV-positive inmates did not know they had these infections. More than 90% of the participants infected by either virus reported being injection drug users before imprisonment. Given these data, the researchers conclude that HIV and HCV antibody testing and counselling should be offered to all inmates entering prison and that education and harm-reduction measures are needed.


'"/>

Contact: Dr. Michel Alary
malary@uresp.ulaval.ca
416-682-7387
Canadian Medical Association Journal
30-Jul-2007


Page: 1

Related biology news :

1. Injection drug use and HIV and HCV infections among Ontario prison inmates
2. Injection may prevent infertility in men receiving cancer chemotherapy
3. New study demonstrates important role of glia in circadian timing
4. News conference on plant diseases and issues important to California
5. Scientists gain important insights into acute promyelocytic leukemia
6. UVa-led team uncovers important secret in gene replication
7. Menthol receptor also important in detecting cold temperatures
8. Virus widely used in gene therapy research yields important clues to genomic instability
9. LIAI scientists make important finding on cytomegalovirus transmission
10. Susceptibility to Crohns disease -- an important new clue
11. Health disparities -- Genetics, society and race play an important role in access to healthcare

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2020)... ... June 24, 2020 , ... eClinical Solutions LLC , ... that accelerate drug development, is collaborating with Karyopharm Therapeutics (Nasdaq: KPTI ) ... with severe COVID-19. This is the first study of an XPO1 inhibitor in ...
(Date:6/23/2020)... ... June 22, 2020 , ... The field of quantitation of large molecules ... have dominated this area. However, the use of mass spectrometry in this field has ... the question “How do you choose which approach to use (LBA or MS)?” ...
(Date:6/19/2020)... ... June 16, 2020 , ... The director of stem cell biotechnology ... the stem cell medicine and pharmaceutical industries have easier access to stem cell counting, ... July 5 of this year, Independence Day weekend in the U.S., Asymmetrex is offering ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... HOUSTON (PRWEB) , ... August ... ... a biopharmaceutical cold chain validation engineering firm, is making available for ... driving the need to incorporate concurrent transport simulation testing into today’s biologics ...
(Date:8/3/2020)... ... August 03, 2020 , ... ... Jim Corrigan, President and CEO has been named one of the 100 most ... industry sectors, PharmaVoice 100 honorees are selected based on how they have inspired ...
(Date:7/31/2020)... , ... July 29, 2020 , ... ... announced the launch of its new tagline, “BUILDING FOR LIFE.” The adoption of ... and around the globe, requiring fast track capacity to provide patients with urgently ...
(Date:7/31/2020)... , ... July 29, 2020 , ... ... Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions ... that they have entered into a strategic partnership whereby Catalent will provide support ...
Breaking Biology Technology:
Cached News: